Immunomodulation by interference with co-stimulatory molecules: Therapeutic perspectives in asthma

Thorax

Volumn 54, Issue 6, 1999, Pages 554-557

  Burastero, Samuele E ^a   Rossi, Giovanni A ^b  

^a San Raf faele Institute   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; INTERLEUKIN 5; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; RECOMBINANT PROTEIN; T LYMPHOCYTE RECEPTOR;

ALLERGIC ASTHMA; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; HELPER CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; KNOCKOUT MOUSE; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE ACTIVATION;

EID: 0033013829     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.6.554     Document Type: Short Survey

References (49)

1. 1 Hance AJ. Accessory cell-lymphocyte interactions. In: Crystal RG, Weibel ER, Barnes PJ, eds. The Lung: Scientific Foundations. 2nd ed. Philadelphia: Lippincott-Raven, 1997: 821-39.
2. 2 Reynolds HY. Immunologic system in the respiratory tract. Physiol Rev 1991;71:1117-33.
3. 3 Chelen CJ, Fang Y, Freeman GJ, et al. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest. 1995;95:1415-21.
4. 4 Nicod LP, Isler P. Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L. Am J Respir Cell Mol Biol 1997;17:91-6.
5. 5 Schon-Hegrad MA, Oliver J, McMenamin PG, et al. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J Exp Med 1991;173:1345-56.
6. 6 Xia W, Pinto CE, Kradin RL. The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen. J Exp Med 1995;181:1275-83.
7. 7 Burastero SE, Rossi GA, Crimi E. Selective differences in the expression of homing receptors of helper lymphocyte subsets. Clin Immunol Immunopathol 1998;89:110-6.
8. 8 June CH, Bluestone JA, Nadler LM, et al. The B7 and CD28 receptor families. Immunoll Today 1994;15:321-31.
9. 9 Mueller DL, Jenkins MK. Molecular mechanisms underlying functional T-cell unresponsiveness. Curr Opin Immunol 1995;7:375-81.
10. 10 Harding FA, McArthur JG, Gross JA, et al. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992;356:607-9.
11. 11 Lindstein T, June CH, Ledbetter JA, et al. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989;244:339-43.
12. 12 Lindsten T, Lee KP, Harris ES, et al. Characterization of CTLA-4 structure and expression on human T cells. J Immunol 1993;151:3489-99.
13. 13 Tivol EA, Borriello F, Schweitzer AN, et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995;3:541-7.
14. 14 Lian RH, Kotwal GJ, Wellhausen SR, et al. IFN-gamma-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate. J Immunol 1996;157: 864-73.
15. 15 Korpelainen EI, Gamble JR, Smith WB, et al. Interferon-gamma upregulates interleukin-3 (IL-3) receptor expression in human endothelial cells and synergizes with IL-3 in stimulating major histocompatibility complex class II expression and cytokine production. Blood 1995;86:176-82.
16. 16 Albert SE, Strutz, F, Shelton K, et al. Characterization of a cis-acting regulatory clement which silences expression of the class II-A beta gene in epithelium. J Exp Med 1994;180:233-40.
17. 17 Bland PW, Whiting CV. Differential control of major histocompatibility complex class II I-Ek alpha protein expression in the epithelium and in subsets of lamina propria antigen-presenting cells of the gut. Immunology 1993;79: 107-11.
18. 18 Savage CO, Brooks CJ, Harcourt GC, et al. Human vascular endothelial cells process and present autoantigen to human T cell lines. Int Immunol 1995;7:471-9.
19. 19 Seino K, Azuma M, Bashuda H, et al. CD86 (B70/B7-2) on endothelial cells co-stimulates allogeneic CD4+ T cells. Int Immunol 1995;7:1331-7.
20. 20 Bashian GG, Braun CM, Huang SK, et al. Differential regulation of human, antigen-specific Th1 and Th2 responses by the B-7 homologues, CD80s and CD86. Am J Respir Cell Mol Biol 1997;17:235-42.
21. 21 Yi-qun Z, Joost van Neerven RJ, Kasran A, et al. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens. Int Immunol 1996;8: 37-44.
22. 22 Durie FH, Foy TM, Masters SR, et al. The role of CD40 in the regulation of humoral and cell-mediated immunity, Immunol Today 1994;15:406-11.
23. 23 Reul RM, Fang JC, Denton MD, et al. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection. Transplantation 1997;64: 1765-74.
24. 24 Hancock WW, Sayegh MH, Zheng XG, et al. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 1996;93:13967-72.
25. 25 Ranheim EA, Kipps TJ. Activated T cells induce expression of B7/KB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 1993;177:925-35.
26. 26 Guo Y, Wu Y, Shinde S, et al. Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J Exp Med 1996;184:955-61.
27. 27 Borriello F, Sethna MP, Boyd SD, et al. B7-1 and B7 2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997;6:303-13.
28. 28 Schweitzer AN, Borriello F, Wong RC, et al. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. J Immunol 1997;158:2713-22.
29. 29 Schweitzer AN, Sharpe AH. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J Immunol 1998;161:2762-71.
30. 30 Burastero SE, Magnani Z, Confetti C, et al. CD80 expression on alveolar macrophages and presence of airway eosinophils in asthma and in rhinitis before and after allergen challenge. Eur Respir J 1998;12(Suppl 28):112s.
31. 31 Burastero SE, Magnani Z, Confetti C, et al. CD80 molecule expression by alveolar macrophages (AM) is enhanced in allergic asthma and it is involved in allergen presentation to allergen-specific T-cells. Eur Rapir J 1998;12(Suppl 28):159s.
32. 32 Burastero SE, Crimi E, Balbo A, et al. Oligoclonality of lung T lymphocytes following exposure to allergen in asthma. J Immunol 1995;155:5836-46.
33. 33 Burastero SE, Borgonovo B, Gaffi D, et al. The repertoire of T-lymphocytes recovered by bronchoalveolar lavage from healthy nonsmokers. Eur Respir J 1996;9:319-27.
34. 34 Larché M, Till SJ, Haselden BM, et al. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. J Immunol 1998;161:6375-82.
35. 35 Burastero SE, Fenoglio D, Crimi E, et al. Frequency of allergen-specific T lymphocytes in blood and bronchial response to allergen in asthma. J Allergy Clin Immunol 1993;91:1075-81.
36. 36 Borgonovo B, Casorati G, Frittoli E, et al. Recruitment of circulating allergen-specific T lymphocytes to the lung on allergen challenge in asthma. J Allergy Clin Immunol 1997; 100:669-78.
37. 37 Linsley PS, Brady W, Urnes M, et al. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991;174:561-9.
38. 38 Van Oosterhout AJ, Hofstra CL, Shields R, et al. Murine CTLA4-IgG treatment inhibits airway cosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma. Am J Rispir Cell Mol Biol 1997;17:386-92.
39. 39 Krinzman SJ, De Sanctis GT, Cernadas M, et al. Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. J Clin Invest 1996;98:2693-9.
40. 40 Pearson TC, Routenber KL, Abrams J, et al. Prolongation of renal allograft survival with CTLA4Ig in the Rhesus macaque. 17th American Society of Transplant Physicians, Chicago, 1997: 85.
41. 41 Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996;381:434-8.
42. 42 Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997;94:8789-94.
43. 43 Thompson CB. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 1995;81:979-82.
44. 44 Kuchroo VK, Das MP, Brown JA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/h2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80:707-18.
45. 45 Lenschow DJ, Ho SC, Sattar H, et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995;181:1145-55.
46. 46 Keane-Myers A, Gause WC, Linsley PS, et al. B7-CD28/ CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway-responses to inhaled antigens. J Immunol 1997;158:2042-9.
47. 47 Harris N, Peach R, Naemura J, et al. CD80 costimulation is essential for the induction of airway eosinophilia. J Exp Med 1997;185:177-82.
48. 48 Tsuyuki S, Tsuyuki J, Einsle K, et al. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med 1997;185:1671-9.
49. 49 Morton PA, Fu XT, Stewart JA, et al. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). J Immunol 1996;156:1047-54.